June 8, 2021
1169082 B.C. Ltd. and Awakn Life Sciences Inc. are pleased to announce the closing of the previously announced brokered private placement.
April 27, 2021
DEFINING CLEAR DEVELOPMENT PATHWAY FOR NEXT GENERATION OF PSYCHEDELIC MEDICINES TO TREAT ADDICTION Awakn Life Sciences Inc. (Awakn), a biotechnology...
July 8, 2020
Professor David Nutt is a world renowned neuroscientist, leading global authority on drug policy reform and former chief drug advisor...
June 18, 2020
Psychedelic Medical Start-Up AWAKN Life Sciences Enters the UK Market with Dr. Ben Sessa